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BACKGROUND OF 2015 GUIDELINES FOR ADULT ADVANCED LIFE 
SUPPORT
The chain of survival suggested in the 2015 Korean cardiopulmonary resuscitation (CPR) guide-
lines consists of the five links of prevention and early detection of cardiac arrest, early access, 
early cardiopulmonary resuscitation, early defibrillation, and effective advanced life support (ALS) 
and post-cardiac arrest care. ALS, which constitutes the last link, should immediately follow the 
basic life support (BLS) if the required manpower, equipment, and drugs are available. ALS in-
cludes the following elements: quick recognition of cardiac arrest and activation of the resusci-
tation team; immediate CPR, manual defibrillation, and pharmacological therapy; and advanced 
airway management and monitoring of physiological parameters.1 Comprehensive post-cardiac 
arrest care, which begins immediately after recovery of spontaneous circulation, is also included 
in ALS. Improvements in the survival and neurologic outcomes in patients with cardiac arrest 
can be expected only when BLS and ALS are provided in combination. In case of in-hospital car-
diac arrest, effective BLS begins with the first responder quickly confirming cardiac arrest, im-
mediately calling for help, asking for manual defibrillator while calling the resuscitation team in 
the hospital, and conducting a high-quality CPR. The most important principle in cardiac arrest 
treatment through ALS is that it should be based on effective BLS. When ventricular fibrillation 
(VF) or pulseless ventricular tachycardia (VT) occurs, the survival rate can be increased with im-
mediate CPR and early defibrillation conducted by the witness. Advanced airway management, 
mechanical chest compression devices, and extracorporeal circulation devices increase the short-
term survival rate including the return of spontaneous circulation (ROSC) and survival admis-
sion.2-7 However, the evidence supporting that these improve the survival or neurologic out-
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comes at hospital discharge is still insufficient. Long-term survival 
of patients who recover their spontaneous circulation can be im-
proved when combined post-cardiac arrest treatment, which in-
cludes targeted temperature management and percutaneous cor-
onary intervention, is provided in association with high-quality 
BLS and effective ALS.8-15 The incidence rate of in-hospital cardi-
ac arrest can be decreased by early recognition of patients with 
deteriorating condition indicating an impending cardiac arrest 
and responding immediately.16
 The major issues of ALS described in the 2015 Korean CPR 
guidelines maintained the basic principles suggested in the 2011 
Korean CPR guidelines. The 2015 guidelines continue to empha-
size on the importance of immediate and effective CPR (chest 
compression with adequate depth and rate, sufficient relaxation, 
minimal interruption of chest compression, and prevention of hy-
perventilation) in patients who experience cardiac arrest.17-21 
During CPR, the ALS provider uses available monitoring devices, 
such as end-tidal carbon dioxide (ETCO2) monitoring devices and 
pulse oximeter, supplies oxygen via advanced airway, and con-
ducts manual defibrillation. Furthermore, during ALS, the provider 
finds the reversible causes of cardiac arrest and corrects them if 
possible. As ways of advanced airway management, the use of 
supraglottic airway devices (e.g., laryngeal mask airway, laryngeal 
tube, i-gel) is recommended in addition to endotracheal intuba-
tion.22-24 However, the guideline emphasizes that chest compres-
sion should not be delayed due to advanced airway management 
conducted during CPR. 
HIGHLIGHTS OF 2015 GUIDELINES FOR 
ADULT ALS
The key issues and the major highlights of the 2015 Korean 
guidelines for ALS include the following. Monitoring physiologic 
parameters during CPR provides meaningful information about 
the patient’s condition and response to CPR. These parameters 
can be monitored continuously, without interrupting chest com-
pression. The use of quantitative waveform capnography for 
monitoring of the partial pressure of ETCO2 is recommended after 
advanced airway management. Capnography is useful for evalu-
ating the effectiveness of chest compression and the possibility 
of the ROSC during CPR.25,26 Low ETCO2 in intubated patients af-
ter 20 minutes of CPR is associated with poor chances for ROSC 
and survival.26,27 When quantitative capnography is used after 
endotracheal intubation, the healthcare providers can confirm an 
intratracheal placement of endotracheal tube.28,29
 With regard to vasopressors for cardiac arrest treatment, the 
combination of vasopressin and epinephrine offers no advantage 
over the standard-dose epinephrine. Vasopressin has been re-
moved from the adult out-of-hospital cardiac arrest algorithm. 
However, as per the 2015 Korean CPR guidelines for ALS, vaso-
pressin may provide some benefit when bundled with epinephrine 
and steroids in treating in-hospital cardiac arrest.30,31
 Although mechanical chest compression devices have been 
developed and are currently being used in cardiac arrest patients, 
the use of such devices as a routine alternative to the conven-
tional CPR is not recommended. Manual chest compression re-
mains the standard care for cardiac arrest; however, in certain 
circumstances (e.g., in case of limited manpower or prolonged 
CPR, when in a moving ambulance or helicopter, in the angiogra-
phy room, or during preparation of extracorporeal CPR [ECPR]), 
the use of mechanical chest compression devices can be consid-
ered as a reasonable alternative to high-quality chest compres-
sion.5,32,33 ECPR is a complex intervention that requires a highly 
trained team, specialized equipment, and multidisciplinary sup-
port. Only for selected patients who have a cardiac arrest and for 
whom the suspected etiology of cardiac arrest is potentially re-
versible, ECPR may be considered an alternative to conventional 
CPR.6,7
CARDIAC ARREST ALGORITHM IN ADULT
Because the necessity of defibrillation and the drugs adminis-
tered for treatment of cardiac arrest differ depending on electro-
cardiography (ECG) rhythms, understanding of the entire algo-
rithm and initial ECG rhythms is essential for effective ALS. Car-
diac rhythms during cardiac arrest include shockable rhythms (VF 
and pulseless VT) and non-shockable rhythms (asystole and 
pulseless electrical activity [PEA]). BLS and early defibrillation, 
rather than advanced airway management or drug administra-
tion, are the most important and preferentially provided treat-
ment in cardiac arrest. Few drugs used in the treatment of cardi-
ac arrest are supported by evidence. After starting CPR and at-
tempting defibrillation, rescuers can establish intravenous (IV) 
access, considering drug administration, and then insert an ad-
vanced airway. 
 As in the 2011 guideline, the 2015 guideline combines the 
treatment processes of cardiac arrest into a universal algorithm; 
this also corresponds to the “megacode concept” used in ALS ed-
ucation. In other words, because changes in ECG rhythms may 
occur during ALS provided for cardiac arrest, a combined algo-
rithm, rather than separate algorithms for each ECG rhythm, can 
be more effectively used in clinical field. For instance, the scenar-
io in which “VF occurs while treating asystole, and spontaneous 
circulation is recovered after defibrillation,” could occur in prac-
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tice; in such cases, if VF is observed while treating asystole, the 
treatment direction should change to treat VF first. 
 The treatment of cardiac arrest starts with BLS. BLS includes 
the recognition of the patient, confirmation of cardiac arrest, call 
for help, and immediate beginning CPR. Regardless of the ECG 
rhythm, push hard and fast and release completely in chest com-
pression. Moreover, to minimize the fatigue of the chest com-
pressors, the CPR team leader should switch the roles with the 
compressor approximately every 2 minutes (or after 5 cycles of 
compressions and ventilations at a ratio of 30:2). Healthcare pro-
viders should interrupt chest compressions as infrequently as 
possible and try to limit interruptions to no longer than 10 sec-
onds except for specific interventions such as use of a defibrilla-
tor or analyzing the ECG rhythms through monitors, confirmation 
of pulse for confirmation of spontaneous circulation (when per-
fusing rhythm appears on ECG), and insertion of an advanced air-
way. As ways to evaluate the effectiveness and quality of CPR, 
there are a number of methods and emerging technologies to 
monitor the patient during CPR and potentially help guide ALS 
interventions (e.g., monitoring of ETCO2 partial pressure, diastolic 
arterial pressure, and central venous oxygen saturation). When an 
advanced airway is not in placement, chest compression and res-
cue ventilation should to be conducted in a 30:2 ratio; when the 
advanced airway is secured, chest compression should be con-
ducted at 100–120 times/min while ventilation should be con-
ducted once in 6 seconds (10 times/min).21 Hyperventilation 
should be avoided. Manual defibrillators, rather than automated 
defibrillators, are used in ALS to confirm ECG rhythms and to de-
fibrillate. 
 Although administration of drugs before conducting advanced 
airway management is recommended, depending on the team 
members’ skills as well as the ongoing experience in inserting the 
airway and verifying proper position with minimal interruption of 
chest compression, drug administration and advanced airway 
management can be conducted simultaneously. In patients with 
an initial shockable rhythm, administration of epinephrine (IV or 
intraosseous [IO] injection) immediately after the first shock is 
recommended. In cases of asystole or PEA (non-shockable 
rhythms), early administration of epinephrine can increase the 
ROSC, survival to hospital discharge, and neurologically intact 
survival.34-36 This section discusses in detail the general manage-
ment of patients experiencing cardiac arrest and provides an 
overview of the ALS Cardiac Arrest Algorithm (Fig. 1 and Table 1). 
1. Shockable rhythms (VF/pulseless VT) 
Because VF and pulseless VT can be treated with defibrillation, 
they are referred to as shockable rhythms. The most important 
treatment for VF or pulseless VT is immediate bystander CPR and 
Fig. 1. Adult advanced life support algorithm. CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; VT, ventricular tachycardia; ECG, electro-
cardiography; PEA, pulseless electrical activity; IV, intravenous; IO, intraosseous.
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defibrillation as soon as possible. When VF is found on ECG moni-
tor during CPR, providers should deliver one shock (biphasic defi-
brillator, 120–200J; monophasic defibrillator, 360J) and then re-
sume CPR immediately for 2 minutes, beginning with chest com-
pressions without pulse check or ECG rhythm confirmation. When 
the defibrillation energy dose recommended by the manufacturer 
is not known, defibrillation should be conducted at 200J when a 
biphasic defibrillator is used. During chest compression, an IV or 
IO route for drug administration should be established. ECG 
rhythms should be checked after two minutes of CPR. If VF per-
sists, the second and subsequent energy doses should be equiva-
lent, and higher doses may be considered.37,38 The entire process 
of manual defibrillation should be achievable in less than a 
5-second interruption to chest compression.39,40 
 During chest compression, epinephrine should be injected, and 
bolus IV fluids need to be pushed through the site of injection 
immediately. Meanwhile, another rescuer should perform ad-
vanced airway management. After 2 minutes of chest compres-
sions, analyze the rhythm and deliver another shock immediately 
if indicated. Although 1 mg of epinephrine should be adminis-
tered every 3 to 5 minutes in principle, it can be administered ev-
ery two CPR cycles (4 minutes when rescuers take turns in con-
ducting chest compression every 2 minutes). When VF/pulseless 
VT persists after 2 to 3 shocks, consider administering an antiar-
rhythmic such as amiodarone. Three hundred milligram of amio-
darone is recommended as the first dose; when VF/pulseless VT 
persists, additional 150 mg can be administered after 4 minutes 
from initial administration. If amiodarone is not available, lido-
caine may be considered as an alternative. Although the previous 
2011 guidelines suggested consideration of magnesium adminis-
tration for refractory VF, the new guidelines do not recommend 
routine use of magnesium any more, as it does not result in any 
improvement in survival prognosis.41 
 If the ECG rhythms change to asystole or PEA while treating 
for VF/pulseless VT, the treatment should proceed according to 
the algorithm for non-shockable rhythms. 
2. Non-shockable rhythms (PEA and asystole)
Asystole refers to ventricular asystole; PEA is a heterogeneous 
group of pulseless rhythms that includes pseudo-electromechan-
ical dissociation, idioventricular rhythms, ventricular escape 
rhythms, and bradyasystolic rhythms. As asystole and PEA do not 
require defibrillation during CPR, they are referred to as “non-
shockable rhythms.” PEA is often caused by reversible conditions 
and can be treated if those conditions are identified and correct-
ed. Typical examples of such reversible causes are often referred 
Table 1. Reference table of the adult ALS algorithm  
Core ALS concepts Details
Assess ECG rhythm Rotate a compressor and analyze rhythm every 2 minutes
Defibrillation Biphasic: 
   Initial dose 120 to 200 J (manufacturer recommendation)
   Refractory VF/pulseless VT: escalating doses
Monophasic: 360 J
Chest compression Push hard (5 cm) and fast (100–120/min)
Ensure high quality chest compressions
Start compression within 5 seconds after defibrillation
Use waveform capnography (achieve ETCO2 >10 mmHg after endotracheal intubation or 20 minutes of CPR) 
Advanced airway management 
 and ventilation
Keep bag-valve-mask ventilation until advanced airway in place
Perform endotracheal intubation or use a supraglottic airway
Give 1 breath every 6 seconds (10 breaths/min) with continuous chest compressions  
Avoid hyperventilation
Drug administration (IV/IO) 
   All cardiac arrest
  
  
   Refractory VF/pulseless VT
Epinephrine: 1 mg every 3 to 5 minutes (every two CPR cycle as equal to 4 minutes) 
Vasopressin: 40 IU (replace first or second dose of epinephrine)
   Hospitals that already use vasopressin may continue to use
   Bundled regimen of epinephrine, vasopressin and steroid may be considered in in-hospital cardiac arrest
Amiodarone: 300 mg bolus (first dose), 150 mg (second dose)
Lidocaine (as an alternative if amiodarone is not available): 1-1.5 mg/kg (first dose), 0.5-0.75 mg/kg (second dose)
Treat reversible causes H ypovolemia, hypoxia, hydrogen ion (acidosis), hypothermia, hypo/hyperkalemia, tension pneumothorax, toxins,  
tamponade-cardiac, thrombosis-coronary or pulmonary 
Consider additional CPR modalities Ultrasound imaging
Mechanical chest compressions
Extracorporeal CPR
ALS, advanced life support; ECG, electrocardiography; ETCO2, end-tidal carbon dioxide; CPR, cardiopulmonary resuscitation; IV, intravenous; IO, intraosseous; VF, ventricular 
fibrillation; VT, ventricular tachycardia.
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to as the “5Hs and 5Ts”: hypovolemic shock, hypoxia, hyperkale-
mia or hypokalemia, hydrogen ions (metabolic acidosis), hypo-
thermia (the 5Hs), thromboembolism of the pulmonary artery 
(pulmonary embolism), thrombosis of the coronary artery (myo-
cardial infarction), tension pneumothorax, cardiac tamponade, 
and toxins (the 5Ts). Survival from cardiac arrest with asystole is 
poor. Of note, the hope for resuscitation is to identify and treat a 
reversible cause of non-shockable rhythms. 
 If the ECG rhythm is non-shockable, chest compression should 
be immediately performed for 2 minutes. If the QRS complex can 
be confirmed in PEA, the pulse should be quickly checked. If there 
is no pulse, CPR should be conducted for 2 minutes while the 
route (IV or IO) for drug administration is established. Epinephrine 
should be administered every 3 to 5 minutes or every two CPR 
cycles (4 minutes). After 2 minutes of chest compression, rhythms 
should be analyzed. If asystole or PEA persists, chest compression 
should be continued, and then advanced airway management 
should be conducted. Atropine is no longer used in treatment of 
asystole.
3. Immediate post-cardiac arrest treatment
Post-cardiac arrest care is offered to patients whose spontaneous 
circulation has recovered as a result of ALS care. Integrated post-
cardiac arrest treatment, which includes hemodynamic stabiliza-
tion, adequate ventilation and controlling of blood oxygen satu-
ration, targeted temperature management, and percutaneous 
coronary intervention for acute coronary syndrome, should be 
provided immediately after the recovery of spontaneous circula-
tion. 
4. In-hospital resuscitation
For all in-hospital cardiac arrests, cardiopulmonary arrest should 
be recognized immediately and CPR should be started immedi-
ately; if indicated, defibrillation is attempted as soon as possible 
and certainly within 3 minutes. The importance of “prevention 
and early detection of cardiac arrest,” which is the first link sug-
gested in the 2015 CPR guidelines, is emphasized not only in out-
of-hospital cardiac arrest, but also in in-hospital cardiac arrest. 
The resuscitation team may take the form of a traditional CPR 
team, which is called only when cardiac arrest is detected. Alter-
natively, hospitals may have strategies to engage rapid response 
teams or medical emergency teams to recognize patients at risk 
of cardiac arrest before cardiac arrest occurs.16,42,43 Contrary to 
out-of-hospital cardiac arrest, vasopressin may provide some 
benefit when bundled with epinephrine and steroid in treating 
in-hospital cardiac arrests.30,31
MONITORING DURING ALS
Monitoring both provider performance and patient physiologic 
parameters during CPR is essential to optimizing CPR quality and 
feedback on the effectiveness of chest compression.44 ETCO2 par-
tial pressure, coronary perfusion pressure, and central venous ox-
ygen saturation can be used as physiological monitoring indices 
during ALS. It is recommended to use quantitative waveform 
capnography in intubated patients to monitor CPR quality, opti-
mize chest compressions, detect ROSC during chest compression 
or when rhythm check reveals an organized rhythm, and confir-
mation of the location of endotracheal intubation.25,26,29 Although 
placement of invasive monitors during CPR is not generally war-
ranted, physiologic parameters such as arterial pressures and 
central venous oxygen saturation, when available, may also be 
helpful in optimizing CPR and detecting ROSC. 
 The main determinant of ETCO2 during CPR is perfusion to the 
lungs. Persistently low ETCO2 values <10 mmHg during CPR in 
intubated patients suggest that ROSC is unlikely. Monitoring the 
ETCO2 during ALS can help in maintaining high-quality chest 
compression and detecting compressor fatigue.45,46 If the ETCO2 
partial pressure is measured to be less than 10 mmHg, the quality 
of ALS should be improved by increasing performance or chang-
ing a compressor. If ETCO2 abruptly increases to a normal value of 
35 to 40 mmHg, it is reasonable to consider this an indicator of 
ROSC. Continued insufficient ETCO2 (<10 mmHg) after intubation 
and 20 minutes after the initial resuscitation is associated with 
extremely poor chances for ROSC and survival outcomes.26,27,47 In 
non-intubated patients (those with bag-mask ventilation or su-
praglottic airway), ETCO2 may not consistently reflect the true 
value, making the measurement less reliable as a prognostic tool.1 
However, the measurement of ETCO2 partial pressure should not 
be used as the single index to monitor the quality of ALS or to 
predict the recovery of spontaneous circulation. 
MEDICATIONS FOR CARDIAC ARREST
High-quality CPR and rapid defibrillation are most important in 
cardiac arrest, and drug administration is considered next. After 
starting CPR and conducting defibrillation, IV or IO access has 
been established for drug administration. The establishment of 
peripheral access is preferred because it does not require inter-
ruption of chest compression. In cases of shockable rhythms, de-
fibrillation should be conducted first, and epinephrine adminis-
tration follows afterward; in cases of non-shockable rhythms, 
drugs should be administered immediately and early once chest 
compression begins and once the IV route is achieved.36 
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1. Epinephrine
Epinephrine is the universal vasopressor used in cardiac arrest 
treatment. Epinephrine stimulates adrenergic receptors, produces 
vasoconstriction, increases blood pressure and heart rate, and 
improves perfusion pressure to the brain and heart. Based on im-
provements in short-term prognosis resulting from epinephrine 
as compared to placebo, administration of standard dose of epi-
nephrine to cardiac arrest patients is recommended. However, it 
is not recommended to add vasopressin to standard-dose epi-
nephrine. High-dose epinephrine is not recommended for routine 
use in cardiac arrest.48 Standard-dose epinephrine (1 mg every 3 
to 5 minutes) is recommended for patients experiencing cardiac 
arrest. The standard protocol used during CPR for adults is as fol-
lows: 1 mg of epinephrine is administered quickly in the form of 
a 1:1,000 ampule or 1:10,000 prefilled syringe formula every 3 to 
5 minutes or every two cycles of chest compression rotation (4 
minutes).49,50 Either IV or IO routes can be used. If IV/IO access is 
delayed or cannot be established, epinephrine may be given by 
the endotracheal route at a dose of 2 to 2.5 mg.51
 The timing of epinephrine administration during CPR depends 
on the cardiac arrest rhythm. In cardiac arrest patients with a 
non-shockable rhythm, early administration of epinephrine is 
suggested.34 Optimal timing of epinephrine cannot be recom-
mended because of insufficient evidence, particularly in relation 
to defibrillation in cardiac arrest due to a shockable rhythm. In 
such cases, early defibrillation, rather than the timing of epineph-
rine administration, should be considered first, and epinephrine is 
quickly administered after that.34,36
2. Vasopressin
Vasopressin is a non-adrenergic peripheral vasoconstrictor that 
increases arterial blood pressure. Vasopressin offers no advantage 
as a substitute for epinephrine in out-of-hospital cardiac arrest. 
The use of vasopressin in treatment of out-of-hospital cardiac ar-
rest as an alternative to epinephrine is no longer recommended. 
However, those healthcare professionals working in systems that 
already use vasopressin may continue to do so because there is 
no evidence of harm from using vasopressin when compared to 
epinephrine.47
 Considering that vasopressin is currently being used in cases of 
in-hospital cardiac arrest, the evidence to support changing the 
existing guideline is also lacking. The effect of vasopressin in car-
diac arrest does not differ from that of epinephrine; therefore, 40 
units of vasopressin can be administered once through an IV or 
IO route to replace the first or second epinephrine administra-
tion.52 Moreover, the “vasopressor bundle” combination therapy, 
which combines steroids, epinephrine, and vasopressin, is being 
suggested as a treatment option for in-hospital cardiac arrest.30,31
3. Antiarrhythmic drug
Although the survival to hospital admission rate was reported to 
increase in a study that investigated the effectiveness of antiar-
rhythmic drugs in refractory VF/pulseless VT, no antiarrhythmic 
drug has yet been shown to increase long-term survival or neuro-
logic outcome after cardiac arrest due to VF/pulseless VT.53 Amio-
darone, however, has been shown to increase short-term survival 
to hospital admission when compared with placebo or lidocaine.54 
Although the use of magnesium was recommended until the 
2011 guidelines when hypomagnesemia was suspected in pa-
tients with cardiac arrest, the new guidelines do not recommend 
routine use of magnesium for adult VF/pulseless VT patients.41 
1) Amiodarone
IV amiodarone affects sodium, potassium, and calcium channels 
as well as α- and β-adrenergic blocking actions. Amiodarone is 
used to treat refractory VF/pulseless VT that does not respond to 
defibrillation. The initial dose of 300 mg can be injected intrave-
nously or intraosseously; if there is no response, a second dose of 
150 mg amiodarone is administered after two cycles of chest 
compression rotation (after 4 minutes).55 
2) Lidocaine
The short-or long-term effects of lidocaine in refractory VF/pulse-
less VT that does not respond to defibrillation or repeats after de-
fibrillation have been investigated in only a limited number of 
studies.56,57 Lidocaine can be considered in cases where amioda-
rone is not available.54 The initial dose is 1 to 1.5 mg/kg IV/IO. Re-
peat if indicated at 0.5 to 0.75 mg/kg over 5- to 10-minute inter-
vals to a maximum of 3 mg/kg. 
ADDITIONAL CONSIDERATIONS DURING ALS 
1. Oxygen supply during CPR 
A study on out-of-hospital cardiac arrest analyzed outcome ac-
cording the arterial oxygen partial pressure during CPR and re-
ported that the survival-to-hospital admission rate increased in 
the group that received high concentration of oxygen.58 When 
supplementary oxygen is available, it may be reasonable to use 
the maximal feasible inspiratory concentration during CPR. After 
the recovery of spontaneous circulation, it is recommended to 
administer the maximum oxygen concentration that can main-
tain the arterial oxygen saturation above 94%. 
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2. Factors that predict the prognosis during CPR 
The ETCO2, which reflects the cardiac output induced by chest 
compression, is the only predicting factor currently being used 
during CPR. Survival prognosis was found to be poor in studies 
that investigated in-hospital and out-of-hospital cardiac arrest 
when ETCO2 was maintained at less than 10 mmHg in cardiac ar-
rest patients with endotracheal intubation even 20 minutes after 
the start of CPR.26,27 Hence, an ETCO2 less than 10 mmHg imme-
diately after intubation and 20 minutes after the initial resuscita-
tion is associated with extremely poor chances for ROSC and sur-
vival.47 The ETCO2 below 10 mmHg that persists even after 20 
minutes of appropriate ALS can be used as a criterion, in associa-
tion with other various factors, to stop ALS. The ETCO2 should not 
be used alone as an indication to terminate resuscitation efforts. 
This index cannot be applied in patients that do not have endo-
tracheal intubation. In cases of a simple non-waveform capnog-
raphy used in pre-hospital care, the measurements can be used 
to confirm endotracheal intubation. However, these are not rec-
ommended for prognostication of survival or as evidence for 
stopping CPR. Multimodal approach to decision of terminating 
resuscitation may be required during CPR. 
3. Application of ultrasonography during CPR 
The evidence supporting the effects of ultrasonography used dur-
ing adult CPR is not sufficient. However, the use of ultrasonogra-
phy may be considered to determine the reversible causes of car-
diac arrest only in cases that ultrasonography would not interfere 
with CPR.59 Although no evidence supports that the use of echo-
cardiography improves the prognosis of cardiac arrest patients, it 
can help in diagnosing the cause of treatable cardiac arrest, in-
cluding cardiac tamponade, pulmonary thromboembolism, myo-
cardial infarction, and aortic dissection. Moreover, it can also be 
used as an alternative of ETCO2 capnography to confirm the loca-
tion of endotracheal intubation during CPR.60 
4. The use of mechanical chest compression devices 
Automated mechanical chest compression devices use a piston 
that compresses the sternum, a band that tightens the thorax, or 
both to conduct CPR. Since the announcement of the 2005 
guidelines, important clinical studies that used mechanical chest 
compression devices were conducted. As the evidence supporting 
effectiveness of mechanical chest compression devices over man-
ual CPR is insufficient yet, manual chest compression remains the 
standard care for cardiac arrest.5,32,33 However, mechanical chest 
compression devices can be used as reasonable alternatives in the 
following cases: when the conventional chest compression is not 
possible, when high-quality chest compression cannot be con-
ducted due to the prolonged CPR, and when there is a lack of 
medical personnel required for CPR. In particular, in certain cir-
cumstances, such as inside a moving ambulance, inside angiogra-
phy rooms, during prolonged CPR, and during ECPR, the use of 
mechanical chest compression devices can be considered as a 
reasonable alternative to high-quality chest compression. 
5. Extracorporeal CPR  
ECPR maintains artificial circulation using extracorporeal devices 
in patients with cardiac arrest who do not response to conven-
tional CPR. It is known to exert positive influences on the survival 
and neurological prognosis of adult cardiac arrest patients; there-
fore, it can be used in selective circumstances.6,7,61 As cannula 
and devices should be inserted into large arteries and veins while 
conducting CPR, special equipment and trained members are re-
quired. ECPR is a complex intervention that requires a highly 
trained team, specialized equipment, and multidisciplinary sup-
port. Only for selected patients who have a cardiac arrest and for 
whom the suspected etiology of cardiac arrest is potentially re-
versible, ECPR may be considered as an alternative to conven-
tional CPR.6,7
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